K Itoh

4.1k total citations
83 papers, 3.4k citations indexed

About

K Itoh is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, K Itoh has authored 83 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Immunology, 31 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in K Itoh's work include Immunotherapy and Immune Responses (39 papers), Immune Cell Function and Interaction (25 papers) and T-cell and B-cell Immunology (20 papers). K Itoh is often cited by papers focused on Immunotherapy and Immune Responses (39 papers), Immune Cell Function and Interaction (25 papers) and T-cell and B-cell Immunology (20 papers). K Itoh collaborates with scholars based in Japan, United States and Taiwan. K Itoh's co-authors include Charles M. Balch, Katsuo Kumagai, Arabella B. Tilden, Akira Yamada, Chris D. Platsoucas, Ryuji Suzuki, Naoko Seki, Akinori Kimura, T. Higuchi and Hiroki Kato and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

K Itoh

83 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Itoh Japan 30 2.2k 875 717 348 309 83 3.4k
Gordon F. Burns Australia 37 1.3k 0.6× 606 0.7× 1.5k 2.0× 423 1.2× 264 0.9× 105 4.0k
Patrizia Scapini Italy 33 3.5k 1.6× 1.1k 1.2× 1.1k 1.6× 170 0.5× 396 1.3× 50 5.0k
Niek de Vries Netherlands 30 1.9k 0.9× 434 0.5× 835 1.2× 496 1.4× 553 1.8× 120 4.2k
Éric Rouvier France 17 2.2k 1.0× 740 0.8× 746 1.0× 569 1.6× 352 1.1× 26 3.6k
François Fossiez France 19 2.8k 1.3× 926 1.1× 520 0.7× 126 0.4× 326 1.1× 24 3.9k
James W. Patterson United States 29 1.6k 0.7× 1.4k 1.6× 974 1.4× 125 0.4× 439 1.4× 92 3.2k
T L Whiteside United States 34 2.3k 1.1× 1.3k 1.5× 682 1.0× 271 0.8× 256 0.8× 82 3.5k
Michael P. Davey United States 32 1.2k 0.6× 307 0.4× 1.0k 1.4× 190 0.5× 381 1.2× 62 2.9k
Smina Aït‐Yahia France 21 4.0k 1.8× 1.3k 1.5× 847 1.2× 141 0.4× 387 1.3× 22 5.0k
C R Maliszewski United States 26 3.4k 1.5× 1.3k 1.4× 1.7k 2.4× 397 1.1× 256 0.8× 34 5.4k

Countries citing papers authored by K Itoh

Since Specialization
Citations

This map shows the geographic impact of K Itoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Itoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Itoh more than expected).

Fields of papers citing papers by K Itoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Itoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Itoh. The network helps show where K Itoh may publish in the future.

Co-authorship network of co-authors of K Itoh

This figure shows the co-authorship network connecting the top 25 collaborators of K Itoh. A scholar is included among the top collaborators of K Itoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Itoh. K Itoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yanagimoto, Hiroaki, Takashi Mine, Ken Yamamoto, et al.. (2006). Immunological evaluation of personalized peptide vaccination with gemcitabine for advance pancreatic cancer patients. Journal of Clinical Oncology. 24(18_suppl). 14029–14029. 1 indexed citations
2.
Shomura, Hiroki, Shigeki Shichijo, Satoko Matsueda, et al.. (2004). Identification of epidermal growth factor receptor-derived peptides immunogenic for HLA-A2+ cancer patients. British Journal of Cancer. 90(8). 1563–1571. 16 indexed citations
3.
Komatsu, Nobukazu, Shigeki Shichijo, M. Nakagawa, & K Itoh. (2004). New multiplexed flow cytometric assay to measure anti‐peptide antibody: a novel tool for monitoring immune responses to peptides used for immunization. Scandinavian Journal of Clinical and Laboratory Investigation. 64(6). 535–546. 68 indexed citations
4.
5.
Kikuchi, Mihoko, Yupaporn Wattanagoon, Ronnatrai Ruangweerayut, et al.. (2001). Strong association of a tumor necrosis factor‐α promoter allele with cerebral malaria in Myanmar. Tissue Antigens. 58(6). 407–410. 50 indexed citations
6.
Hamaguchi, Kazuyuki, Akinori Kimura, Naoko Seki, et al.. (2000). Analysis of tumor necrosis factor‐α promoter polymorphism in type 1 diabetes: HLA‐B and ‐DRB1 alleles are primarily associated with the disease in Japanese. Tissue Antigens. 55(1). 10–16. 34 indexed citations
7.
Yamana, Hideaki & K Itoh. (2000). [Specific immunotherapy with cancer vaccines].. PubMed. 27(10). 1477–88. 3 indexed citations
8.
Mine, Takashi, Kenji Harada, Tomoko Matsumoto, et al.. (2000). CDw108 expression during T‐cell development. Tissue Antigens. 55(5). 429–436. 39 indexed citations
9.
Seki, Naoko, Shintaro Kamizono, Akira Yamada, et al.. (1999). Polymorphisms in the 5′‐flanking region of tumor necrosis factor‐α gene in patients with rheumatoid arthritis. Tissue Antigens. 54(2). 194–197. 34 indexed citations
10.
Higuchi, T., Naoko Seki, Shintaro Kamizono, et al.. (1998). Polymorphism of the 5′‐flanking region of the human tumor necrosis factor (TNF)‐α gene in Japanese. Tissue Antigens. 51(6). 605–612. 401 indexed citations
11.
Tamai, Mami, Setsuro Komiya, Kazuo Mochizuki, et al.. (1997). Correlation Between Vitamin D Receptor Genotypes and Bone Mineral Density in Japanese Patients with Osteoporosis. Calcified Tissue International. 60(3). 229–232. 21 indexed citations
12.
Itoh, K, Atsushi Hayashi, Motoki Nakao, et al.. (1996). Human Tumor Rejection Antigens MAGE. The Journal of Biochemistry. 119(3). 385–390. 29 indexed citations
13.
Fujimaki, Takamitsu, Janet E. Price, D. Fan, et al.. (1996). Selective growth of human melanoma cells in the brain parenchyma of nude mice. Melanoma Research. 6(5). 363–371. 17 indexed citations
14.
Nagao, Yumiko, M Sata, Tatsuya Ide, et al.. (1996). Development and exacerbation of oral lichen planus during and after interferon therapy for hepatitis C. European Journal of Clinical Investigation. 26(12). 1171–1174. 54 indexed citations
15.
Shichijo, Shigeki, et al.. (1995). Expression of the MAGE gene family in human lymphocytic leukemia. Cancer Immunology Immunotherapy. 41(2). 95–103. 26 indexed citations
16.
Hoshino, Tomoaki, Akiko Yamada, J Honda, et al.. (1993). Tissue-specific distribution and age-dependent increase of human CD11b+ T cells.. The Journal of Immunology. 151(4). 2237–2246. 66 indexed citations
17.
Itoh, K, et al.. (1992). Distribution of autologous tumor‐specific cytotoxic T lymphocytes in human metastatic melanoma. International Journal of Cancer. 52(1). 52–59. 11 indexed citations
18.
Parkinson, David, Moshe Talpaz, Sewa S. Legha, et al.. (1989). Interlenkin-2 alone and in combination with other cytokines in melanoma: the investigational approach at the University of Texas M. D. Anderson Cancer Center. Cancer Treatment Reviews. 16. 39–48. 7 indexed citations
19.
Seki, Hiroaki, Masanobu Nanno, K Itoh, et al.. (1989). Molecular heterogeneity of gamma delta T-cell antigen receptors expressed by CD4- CD8- T-cell clones from normal donors: both disulfide- and non-disulfide-linked receptors are delta TCS1+.. Proceedings of the National Academy of Sciences. 86(7). 2326–2330. 19 indexed citations
20.
Itoh, K, Chris D. Platsoucas, & Charles M. Balch. (1988). Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.. The Journal of Experimental Medicine. 168(4). 1419–1441. 275 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gordon F. Burns Breakdown of academic impact, for papers by Patrizia Scapini Breakdown of academic impact, for papers by Niek de Vries Breakdown of academic impact, for papers by Éric Rouvier Breakdown of academic impact, for papers by François Fossiez Breakdown of academic impact, for papers by James W. Patterson Breakdown of academic impact, for papers by T L Whiteside Breakdown of academic impact, for papers by Michael P. Davey Breakdown of academic impact, for papers by Smina Aït‐Yahia Breakdown of academic impact, for papers by C R Maliszewski
Rankless by CCL
2026